Physician

Matthew Paul Vasievich, M.D.

According to 2025 Medicare claims, Matthew Vasievich, M.D. (NPI: 1235576174) practices dermatology in the Ann Arbor, MI market, with the plurality of this provider's patient population coming from Washtenaw, MI. This provider's primary affiliated billing organization is PINNACLE DERMATOLOGY, SC (NPI: 1861930984; TIN: 815095434) and primary practice location at 48103-7602. Vasievich is affiliated with the McAuley Health Partners ACO, LLC (ACO ID: A4588), participating under the MSSP model.

Vasievich's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 576 traditional Medicare patients, billed 4,451 HCPCS/CPT codes, and received $276,572 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,204 prescription claims across 487 beneficiaries totaling $176,717 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 41 records totaling $871. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $27,774 to $276,572. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $99,225 and ending at $176,717. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$138K$277K2017 Medicare payment: $27,774 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $94,413 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $96,823 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $82,419 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $104,772 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $96,630 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $192,366 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $276,572 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017183549$27,774
20184962,092$94,413
20194992,536$96,823
20204292,292$82,419
20214932,495$104,772
20225372,683$96,630
20236914,466$192,366
20245764,451$276,572

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$256K$512K2015 Drug cost: $99,225 (USD; Tot_Drug_Cst)2016 Drug cost: $368,601 (USD; Tot_Drug_Cst)2017 Drug cost: $161,370 (USD; Tot_Drug_Cst)2018 Drug cost: $167,452 (USD; Tot_Drug_Cst)2019 Drug cost: $220,820 (USD; Tot_Drug_Cst)2020 Drug cost: $302,130 (USD; Tot_Drug_Cst)2021 Drug cost: $354,492 (USD; Tot_Drug_Cst)2022 Drug cost: $511,689 (USD; Tot_Drug_Cst)2023 Drug cost: $226,767 (USD; Tot_Drug_Cst)2024 Drug cost: $176,717 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015135365$99,225
2016142341$368,601
2017200429$161,370
2018353851$167,452
2019403948$220,820
20204281,110$302,130
20214761,169$354,492
20224931,226$511,689
20235111,144$226,767
20244871,204$176,717

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths176205$78
11102Biopsy of related skin growth, first growth199232$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more387559$61
17000Destruction of precancer skin growth, 1 growth258304$34
17003Destruction of precancer skin growth, 2-14 growths1941,302$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab26714$96,167
KetoconazoleKetoconazole2588,226$4,669
FluocinonideFluocinonide682,162$4,606
Clobetasol PropionateClobetasol Propionate1233,635$4,555
CalcipotrieneCalcipotriene18840$4,470

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.41$871Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Paul Vasievich, M.D.?

Tedicare shows public-source Medicare data for Matthew Paul Vasievich, M.D. (NPI 1235576174), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Paul Vasievich, M.D. have ACO affiliation data?

Matthew Paul Vasievich, M.D. is shown with ACO affiliation data for McAuley Health Partners ACO, LLC (MSSP, ACO ID A4588).

What billing organization is linked to Matthew Paul Vasievich, M.D.?

Matthew Paul Vasievich, M.D. is linked to PINNACLE DERMATOLOGY, SC (billing NPI 1861930984) in the available physician profile data.

Does Matthew Paul Vasievich, M.D. have Open Payments data?

Matthew Paul Vasievich, M.D. has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.